Form 4: Guardant Health Director Meghan Joyce Reports Stock Transactions
SEC Form 4 Filing
Director Meghan Joyce reports the vesting and subsequent disposition of restricted stock units in Guardant Health, Inc.
Summary
- On November 4, 2024, Meghan V. Joyce, a director of Guardant Health, Inc., reported transactions involving common stock.
- These transactions involved the vesting of 66 restricted stock units (RSUs) and the subsequent disposition of the underlying shares.
- The price per share for both the vesting and disposition was $0.
- Following these transactions, Joyce directly owns 10,544 shares of Guardant Health common stock and 598 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| August 4, 2022 | Initial vesting date for 25% of the restricted stock units. |
| November 04, 2024 | Date of the reported transaction involving vesting and disposition of restricted stock units. |
| November 05, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.